Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bancroft Charles A
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   168,937    

Indirect Shares

   300,000      
Direct Value   $6,424,696    

Indirect Value

   $12,702,000      
Total Shares   468,937      
Total Value   $19,126,696      


Bristol-Myers Squibb Co $5,823,190 Colgate Palmolive Co $516,916 Kodiak Sciences Inc. $84,590 Bristol-Myers Squibb Co $5,823,190 Colgate Palmolive Co $516,916 Kodiak Sciences Inc. $84,590
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, Head of Integration 2020-03-10 137,534 2020-03-10 300,000    Premium*  
            Colgate Palmolive Co CL Director 2018-05-14 5,455 2017-05-15 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-04-02 25,948 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co Chief Financial Officer   •       –      –    2011-03-03 4 OE $0.00 $0 D/D 2,487 43,270 0 -
BMY Bristol-Myers Squibb Co Chief Financial Officer   •       –      –    2011-03-04 4 OE $0.00 $0 D/D 2,052 44,417 0 -
BMY Bristol-Myers Squibb Co Chief Financial Officer   •       –      –    2011-03-06 4 OE $0.00 $0 D/D 1,412 45,083 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-01 4 OE $0.00 $0 D/D 9,747 54,316 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-02 4 OE $0.00 $0 D/D 5,658 58,111 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-03 4 OE $0.00 $0 D/D 2,487 59,695 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-04 4 OE $0.00 $0 D/D 2,052 60,842 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-06 4 OE $0.00 $0 D/D 11,325 71,421 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2012-12-17 4 OE $23.14 $1,191,115 D/D 47,125 113,920 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-03 4 OE $0.00 $0 D/D 2,487 73,563 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 OE $0.00 $0 D/D 69,542 142,348 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-02-14 4 OE $22.73 $870,038 D/D 36,251 130,266 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 OE $0.00 $0 D/D 121,014 199,850 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-06 4 OE $0.00 $0 D/D 7,323 159,626 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-10 4 OE $0.00 $0 D/D 6,410 165,472 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-11-01 4 OE $0.00 $0 D/D 3,102 99,666 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-02 4 OE $0.00 $0 D/D 57,926 170,514 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-02 4 OE $0.00 $0 D/D 9,747 108,016 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-06 4 OE $0.00 $0 D/D 7,323 171,251 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4/A OE $0.00 $0 D/D 13,239 163,538 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4 OE $0.00 $0 D/D 13,239 184,290 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-11-01 4 OE $0.00 $0 D/D 3,100 163,957 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-06 4 OE $0.00 $0 D/D 7,324 169,885 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 OE $0.00 $0 D/D 75,618 247,158 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A OE $0.00 $0 D/D 75,618 240,329 0 -
  117  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us